The highest HAS2 staining intensities were detected in benign tumors and in grade 1 carcinomas (Table 2) and the intensities (graded into three categories) was significantly different in the histological subgroups (Chi-square P = 0.003). This evidence concerns the gene HAS2 and benign neoplasm.